Pages that link to "Q48495593"
Jump to navigation
Jump to search
The following pages link to Actions of betahistine at histamine receptors in the brain (Q48495593):
Displaying 50 items.
- Neuropharmacology of vestibular system disorders (Q24624927) (← links)
- Plasticity of histamine H3 receptor expression and binding in the vestibular nuclei after labyrinthectomy in rat (Q24793592) (← links)
- International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors (Q26827568) (← links)
- Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases (Q28066691) (← links)
- Optimizing the pharmacological component of integrated balance therapy (Q28302554) (← links)
- Betahistine effects on cochlear blood flow: from the laboratory to the clinic. (Q30886839) (← links)
- Monoaminergic Control of Cellular Glucose Utilization by Glycogenolysis in Neocortex and Hippocampus. (Q30980023) (← links)
- Betahistine: a retrospective synopsis of safety data (Q31069695) (← links)
- The physiology of brain histamine. (Q31875011) (← links)
- Histamine influences body temperature by acting at H1 and H3 receptors on distinct populations of preoptic neurons (Q33782806) (← links)
- Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes (Q34239455) (← links)
- Acute effects of betahistine hydrochloride on food intake and appetite in obese women: a randomized, placebo-controlled trial (Q34308035) (← links)
- Menière's disease: pathophysiology and treatment. (Q34315080) (← links)
- Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo (Q34321223) (← links)
- Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action (Q34432126) (← links)
- The histamine H3 receptor and its ligands (Q34483311) (← links)
- An LC-MS/MS assay for the quantitative determination of 2-pyridyl acetic acid, a major metabolite and key surrogate for betahistine, using low-volume human K2 EDTA plasma (Q36079992) (← links)
- Management of acute vertigo with betahistine (Q36258766) (← links)
- A third histamine receptor subtype: Characterisation, localisation and functions of the H3-receptor (Q36586117) (← links)
- Modulation of histamine synthesis and release in brain via presynaptic autoreceptors and heteroreceptors (Q36601233) (← links)
- Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability (Q36619798) (← links)
- The influence of betahistine on the dynamics of the cutaneous hypersensitivity reaction in patients with grass pollen allergy (Q36685252) (← links)
- Influence of histamine receptor antagonists on the dynamics of the cutaneous hypersensitivity reaction in patients infected with schistosoma haematobium (Q36741737) (← links)
- Bioinformatics analysis of the gene expression profile of hepatocellular carcinoma: preliminary results (Q36792873) (← links)
- Allergy and Ménière's disease (Q36994661) (← links)
- Betahistine in the treatment of vertiginous syndromes: a meta-analysis (Q37072674) (← links)
- Benign paroxysmal positional vertigo: a study of two manoeuvres with and without betahistine. (Q37091787) (← links)
- Betahistine in the treatment of Ménière's disease. (Q37126812) (← links)
- Functional pharmacology of H1 histamine receptors expressed in mouse preoptic/anterior hypothalamic neurons (Q37327413) (← links)
- Histamine H3 Receptor as a Drug Discovery Target (Q37808205) (← links)
- Allergic and Immunologic Features of Ménière's Disease (Q37881269) (← links)
- Evidence that histamine homologues discriminate between H3-receptors in guinea-pig cerebral cortex and ileum longitudinal muscle myenteric plexus (Q38527186) (← links)
- Use of betahistine in the treatment of peripheral vertigo (Q38561370) (← links)
- Histamine receptors in the central nervous system (Q38733839) (← links)
- Histamine receptors in the mammalian central nervous system: biochemical studies (Q39297182) (← links)
- Developments in histamine H1-receptor agonists (Q40465197) (← links)
- Antivertigo medications and drug-induced vertigo. A pharmacological review (Q40961261) (← links)
- The pharmacological treatment of Menière's disease (Q41010957) (← links)
- Medical Management of Meniere's Disease (Q41601531) (← links)
- Characterization of histamine-H3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea-pig isolated ileum (Q41843309) (← links)
- The histamine autoreceptor is a short isoform of the H₃ receptor (Q41871692) (← links)
- Do H3-receptors participate in the effects of histamine on electrically-evoked contractions of rat vas deferens? (Q41954458) (← links)
- Medial vestibular nucleus in the guinea-pig: histaminergic receptors. II. An in vivo study (Q42622310) (← links)
- Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease (Q42661731) (← links)
- Betahistine dihydrochloride interaction with the histaminergic system in the cat: neurochemical and molecular mechanisms (Q44050769) (← links)
- Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial. (Q46433138) (← links)
- Non-imidazole histamine H3 ligands. Part I. Synthesis of 2-(1-piperazinyl)- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole derivatives as H3-antagonists with H1 blocking activities (Q46878767) (← links)
- Histamine and antipsychotic drug-induced weight gain (Q47269949) (← links)
- Betahistine decreases olanzapine-induced weight gain and somnolence in humans (Q47328428) (← links)
- Betahistine dihydrochloride transdermal delivery via optimized thermosensitive gels: percutaneous absorption evaluation using rat growth as a biomarker (Q47437755) (← links)